Beyond Air (XAIR) Competitors $0.28 -0.01 (-4.58%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$0.29 +0.01 (+4.59%) As of 08:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XAIR vs. SRTS, MLSS, NTRB, VANI, CTSO, GUTS, ICAD, MBOT, ECOR, and INOShould you be buying Beyond Air stock or one of its competitors? The main competitors of Beyond Air include Sensus Healthcare (SRTS), Milestone Scientific (MLSS), Nutriband (NTRB), Vivani Medical (VANI), Cytosorbents (CTSO), Fractyl Health (GUTS), iCAD (ICAD), Microbot Medical (MBOT), electroCore (ECOR), and Inovio Pharmaceuticals (INO). These companies are all part of the "medical equipment" industry. Beyond Air vs. Sensus Healthcare Milestone Scientific Nutriband Vivani Medical Cytosorbents Fractyl Health iCAD Microbot Medical electroCore Inovio Pharmaceuticals Sensus Healthcare (NASDAQ:SRTS) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability. Do insiders and institutionals have more ownership in SRTS or XAIR? 25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 9.4% of Sensus Healthcare shares are owned by insiders. Comparatively, 20.1% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation and earnings, SRTS or XAIR? Sensus Healthcare has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.81M1.85$6.65M$0.4011.73Beyond Air$3.02M6.40-$60.24M-$1.06-0.27 Is SRTS or XAIR more profitable? Sensus Healthcare has a net margin of 15.90% compared to Beyond Air's net margin of -1,730.00%. Sensus Healthcare's return on equity of 12.60% beat Beyond Air's return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare15.90% 12.60% 11.38% Beyond Air -1,730.00%-226.01%-109.75% Which has more volatility & risk, SRTS or XAIR? Sensus Healthcare has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Does the MarketBeat Community believe in SRTS or XAIR? Sensus Healthcare received 137 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 68.77% of users gave Sensus Healthcare an outperform vote. CompanyUnderperformOutperformSensus HealthcareOutperform Votes18568.77% Underperform Votes8431.23% Beyond AirOutperform Votes4869.57% Underperform Votes2130.43% Does the media favor SRTS or XAIR? In the previous week, Beyond Air had 3 more articles in the media than Sensus Healthcare. MarketBeat recorded 4 mentions for Beyond Air and 1 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.89 beat Beyond Air's score of 0.99 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Overall Sentiment Sensus Healthcare Very Positive Beyond Air Positive Do analysts rate SRTS or XAIR? Sensus Healthcare currently has a consensus price target of $13.00, indicating a potential upside of 177.19%. Beyond Air has a consensus price target of $3.67, indicating a potential upside of 1,204.40%. Given Beyond Air's higher possible upside, analysts plainly believe Beyond Air is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Beyond Air 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummarySensus Healthcare beats Beyond Air on 11 of the 17 factors compared between the two stocks. Remove Ads Get Beyond Air News Delivered to You Automatically Sign up to receive the latest news and ratings for XAIR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAIR vs. The Competition Export to ExcelMetricBeyond AirSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.34M$4.42B$5.65B$8.06BDividend YieldN/A32.64%4.57%4.01%P/E Ratio-0.2728.8723.1419.03Price / Sales6.4050.00385.7893.17Price / CashN/A51.0838.1634.64Price / Book1.046.146.934.33Net Income-$60.24M$67.64M$3.20B$247.06M7 Day Performance4.81%-2.07%-2.30%-0.37%1 Month Performance4.19%-0.48%2.86%-3.85%1 Year Performance-83.84%12.88%10.66%1.27% Beyond Air Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAIRBeyond Air4.5857 of 5 stars$0.28-4.6%$3.67+1,204.4%-83.8%$19.34M$3.02M-0.2770SRTSSensus Healthcare2.386 of 5 stars$4.87+4.6%$13.00+167.2%+19.6%$80.27M$41.81M12.1740MLSSMilestone Scientific1.0142 of 5 stars$0.92-0.2%$1.25+35.4%+71.6%$71.89M$8.88M-13.1830NTRBNutriband3.3118 of 5 stars$6.40+3.2%$13.00+103.1%+62.2%$71.08M$2.02M-9.0110Short Interest ↓Positive NewsVANIVivani Medical3.0144 of 5 stars$1.10+0.5%$4.00+265.3%-37.8%$64.86MN/A-2.4320Analyst ForecastNews CoverageCTSOCytosorbents2.1554 of 5 stars$1.15+4.5%$4.67+305.8%+7.5%$62.88M$33.79M-3.19220Upcoming EarningsAnalyst ForecastGap UpGUTSFractyl Health2.1878 of 5 stars$1.29+0.4%$10.00+678.2%-82.5%$62.86M$93,000.00-0.11102Positive NewsICADiCAD0.5107 of 5 stars$2.29flatN/A+33.8%$60.91M$18.94M-17.65140Analyst UpgradePositive NewsMBOTMicrobot Medical1.6587 of 5 stars$1.66+7.5%$9.00+443.8%+33.0%$57.50MN/A-2.0720Earnings ReportECORelectroCore2.4074 of 5 stars$8.40-1.9%$25.50+203.6%+16.0%$55.91M$23.33M-4.5950Short Interest ↑High Trading VolumeINOInovio Pharmaceuticals3.8743 of 5 stars$2.15+5.7%$12.40+478.1%-86.5%$55.85M$203,413.00-1.02320 Remove Ads Related Companies and Tools Related Companies Sensus Healthcare Competitors Milestone Scientific Competitors Nutriband Competitors Vivani Medical Competitors Cytosorbents Competitors Fractyl Health Competitors iCAD Competitors Microbot Medical Competitors electroCore Competitors Inovio Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XAIR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beyond Air With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XAIR Stock Free XAIR Stock Alerts